Introduction Paget’s disease of bone (PDB) is a disorder of bone metabolism reported to affect up to 3% of Caucasian over 55 years of age. PDB is a genetically heterogeneous disorder characterized by abnormal osteoclastic activity leading to bone destruction and macroscopic deformities, which cause bone pain and pathological fractures. There is evidence of genetic [...]
Familial Paget’s disease accounts for about 20% of PDB cases, and it is often found to segregate in an autosomal dominant pattern. Mutations of p62/sequestosome 1 gene (SQSTM1/p62) account for familial forms of PDB. It is well known that the presentation of familial PDB is most frequently poliostotic than in sporadic cases, and that levels [...]
Case presentation A 65 years-old Italian woman came to our attention at the Me- dicina-Malattie Metaboliche dell’Osso Department. She came as an outpatient and the reason of the visit was persistent bone pain. Through family history of the patient, it was possible to ascertain a familial form of Paget’s disease of bone (PDB), because the [...]
Management of patients with Paget’s disease can be challenging. The mainstay of treatment is to relieve pain and improve function. This often necessitates administration of nonsteroidal anti-inflammatory medications and other analgesics. In order to retard excessive osteoclastic activity bisphosphonate drugs may be administered. Joint arthroplasty for Paget’s patients with end-stage symptomatic arthritis may be indicated. [...]